» This issue of Foot and Ankle Quarterly highlights soft tissue mass tumors of the lower extremity.
As podiatric surgeons, we encounter these pathologies in our practices, work them up, and determine treatment plans that optimize patient care. After a thorough history and physical, we incorporate biopsies, advanced imaging modalities, and multidisciplinary consultations to obtain the diagnosis and, ultimately, a cure.
The World Health Organization (WHO) published its fifth edition of the WHO Classification of Tumors of Soft Tissue and Bone in 2020, organizing these tumors based on their line of differentiation. In this issue, my colleague Dr. William Harris, IV and I will present two audio lectures based on this system of histological classifications. We will discuss benign and malignant soft tissue masses, including a review of the literature, our experiences, and algorithms to aide in treatment. This edition’s Feature Article from Dr. Kittra Owens expertly addresses the tumors that we encounter most frequently in the lower extremity.
My colleagues and collaborators from the Michael J. Crescenz VA Medical Center and the University of Pennsylvania were instrumental in providing commentaries on timely articles, which are supported by their extensive knowledge on the issues and their commitment to patient care. Each of their commentaries emphasize performing a thorough work-up that utilizes advanced medical imaging.
In addition to supporting that guidance, I urge all of us to develop relationships with multidisciplinary specialists, especially surgical oncologists and musculoskeletal radiologists, who are indispensable members of our treatment teams.
The ideas and opinions expressed in Foot and Ankle Quarterly are those of the authors and do not necessarily reflect those of the Editor or the Publisher. Publication of an advertisement or other product mentioned in Foot and Ankle Quarterly should not be construed as an endorsement of the product of the manufacturer’s claims. Readers are encouraged to contact the manufacturer with any questions about the features or limitations of the products mentioned. The Publisher does not assume any responsibility for any injury and/or damage to any persons or property arising out of or related to any use of the material contained in this periodical. The reader is advised to check the appropriate medical literature and the product information currently provided by the manufacturer of each device or of each drug to be administered to verify the dosage, the method and duration of administration, or contraindications. It is the responsibility of the treating physician or other healthcare professionals, relying on independent experience and knowledge of the patient, to determine drug dosages and the best treatment for the patient.
Data Trace Publishing Company Continuing Education Mission Statement Data Trace Publishing Company is committed to providing high-quality print and internet-based enduring continuing education programs, including lectures, feature articles, and condensations and commentaries on current clinical podiatric topics and medical risk management topics which lead to improved delivery of patient care and help reduce the potential for medical errors. These programs are provided to meet the educational needs of the podiatric medical profession and thereby enhance the quality of patient care.
Program Objectives Foot and Ankle Quarterly (FAQ) is a unique program designed to help today’s podiatric physician manage an ever-increasing flow of information. After completing the Foot and Ankle Quarterly, Volume 32 program, the learner should be better able to: develop and refine a perspective on current treatment recommendations, updates, and advances pertinent to podiatric practice; evaluate the implications of the learned information as it pertains to the diagnosis and treatment of podiatric disorders and societal issues and barriers, and; apply current trends, standards, and best practices into learner’s own practice.
Data Trace Publishing Company Continuing Education Accreditation Statement Data Trace Publishing Company is approved by the Council on Podiatric Medical Education (CPME) as a provider of continuing education in podiatric medicine. Data Trace Publishing Company has approved this activity for a maximum of 6 continuing education contact hours (CECHs). Physicians should claim only the contact hours commensurate with the extent of their participation in the activity.
Estimated time to complete activity: 6 hours Date of release: October 15, 2021 Expiration Date: November 1, 2024 (unless further validated and extended by provider). For amended dates of activity expiration, please see FAQ Activity Effective Dates at www.datatrace.com).
No commercial interest provided financial support for this continuing education activity.
CECH Note Participants of Volume 32, Issue 3 will receive a maximum of 6 CECHs for a correctly-completed CME Answer Form. In order to qualify for CECHs, a score of 70% or more must be achieved on the written examination material. Any participant who does not pass the first time may take the exam one additional time (within 90 days of receipt of results). One retake test may be taken for a fee of $15. You will be responsible for notifying your state of the number of contact hours you have received.
Participants are required to complete a course evaluation for use in developing future issues and to meet the unique educational needs of podiatric physicians.
FINANCIAL DISCLOSURE INFORMATION It is the policy of Data Trace Publishing Company to ensure balance, independence, objectivity, and scientific rigor in all of its educational programs. All faculty, presenters, speakers, authors, and reviewers participating in any programs provided by Data Trace Publishing Company are expected to disclose any relevant financial relationships with CPME-defined commercial interests to the program audience. “Relevant financial relationships” are financial relationships of the individual (including those of the individual’s spouse or partner) in any amount occurring within the past 12 months that create a conflict of interest. A commercial interest is any organization manufacturing, producing, marketing, re-selling, or distributing healthcare goods or services consumed by or used on patients. The CPME mandates that the content of accredited activities be objective and independent of commercial bias. The intent of this policy is that readers may form their own judgements about the presentations, using independent review to resolve all identified conflicts of interest.
In addition to disclosing commercial relationships, faculty are advised of the following policies:
Each continuing education planner and author has submitted a Conflict of Interest Disclosure in order to identify relevant financial relationships and resolve conflicts.
Limitations on Data: Presenter will ensure, to the extent possible, meaningful disclosure of limitations on data (e.g., ongoing research, interim analyses, preliminary data, or unsupported opinion).
Discussion of Unapproved Uses: If unapproved (unlabeled) uses are discussed during the continuing education activity, the presenter will disclose when a product is not approved in the United States (and/or the nation where the activity takes place) for the use under discussion.
Data Trace Publishing Company has identified the option to disclose as follows:
The following authors have disclosed whether they or a member of their immediate family:
Will be receiving an honorarium for this activity
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they willrefer as speaker or author:
Received monetary or other significant research support
Are or had been a paid consultant
Are or had been a full-time or part-time employee
Are or had been a paid or unpaid member of an advisory or similar board
Are or had been a member or on the Board of Trustees
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they will refer as speaker or author, BUT will not be recommending any of their products over similar competitor products
Within the past 12 months, had a financial or other significant relationship with a commercial organization that markets a product to which they willrefer as speaker or author, AND will be recommending one or more of their products over similar competitor products. Recommendation will be based on:
Exclusively on data and/or clinical experience not generated by the manufacturer or derived from manufacturer-sponsored studies
Data and/or clinical experience most of which were not generated by the manufacturer or derived from manufacturer-sponsored studies
Data and/or clinical experience, most of which were generated by the manufacturer or derived from manufacturer-sponsored studies
Exclusively on data and/or clinical experience generated by the manufacturer or derived from manufacturer or derived from manufacturer-sponsored studies
Have no conflicts to disclose
Article Authors and Lecturers
Amy E. Bruce, DPM (n.)
Susan Gamble, DPM (n.)
Karen Galli, DPM (n.)
William Harris, IV, DPM (1. Data Trace Publishing Company)
Lisa R. Hobbs, DPM (n.)
David Low, MD (n.)
Kittra Owens, DPM (1. Data Trace Publishing Company)
Nicholas J. Perfetti, DPM (n.)
Alexander T. Ruutiainen, MD (n.)
Steven Shannon, DPM (n.)
Sarah A. Spizzirri, DPM (n.)
Marija Ugrinich, DPM (1. Data Trace Publishing Company)
Jacob Wynes, DPM (n.)
FAQ Journal Planning Committee
Chrissy Calvert (n.)
Kimberly Collignon (n.)
Lauren Molander (n.)
Stephanie Wu, DPM, MSc (n.)
Marija Ugrinich, DPM, FACFAS Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA; Co-Director, PAVE Committee; Clerkship Director, Podiatric Surgery Residency Program; Clinical Associate Adjunct Professor, Department of Surgery, Temple University School of Podiatric Medicine; Fellow, American College of Foot and Ankle Surgeons
Amy E. Bruce, DPM, AACFAS Staff Physician and Clinical Instructor Foot and Ankle Surgery, Trinity Health of New England Medical Group St. Francis Hospital Medical Center; Associate, American College of Foot and Ankle Surgeons; Former Fellow, Southeast Permanente Foot and Ankle Trauma and Reconstructive Surgery Fellowship
Karen Galli, DPM Director, Podiatric Residency Training, Crescenz VA Medical Center, Philadelphia, PA; Associate Clinical Professor, Department of Surgery, Temple University School of Podiatric Medicine, Philadelphia, PA; Diplomate, American College of Foot and Ankle Surgeons; Diplomate, American Board of Podiatric Medicine
Susan Gamble, DPM Chief of Podiatry, Department of Surgery, Michael J. Crescenz Medical Center, Philadelphia, PA; Clinical Associate Adjunct Professor, Department of Surgery, Temple University School of Podiatric Medicine, Philadelphia, PA; Diplomat, American Board of Multiple Specialties in Podiatry
William Harris, IV, DPM, FACFAS InStride Foot and Ankle Specialists, Lancaster, SC; Founding Member, International Limb Salvage Foundation; Staff, Medical University of South Carolina – Lancaster Medical Center, Lancaster, SC; Staff, Piedmont Medical Center, Rock Hill, SC; Past President, South Carolina Podiatric Medical Association; Delegate, American Podiatric Medical Association; Fellow, American College of Foot and Ankle Surgeons
Lisa R. Hobbs, DPM, FACFAS Christie Clinic, Champaign, IL; Fellow, American College of Foot and Ankle Surgeons; Fellow, American Board of Podiatric Medicine
David W. Low, MD Professor of Surgery, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Attending Surgeon, Division of Plastic Surgery, Children’s Hospital of Philadelphia, Philadelphia, PA
Kittra Owens, DPM, FACFAS, FACPM Section Chief, Podiatry/Foot and Ankle Surgery, Foot and Ankle Surgery GME Site Director, VA Southern Nevada Healthcare System, Las Vegas, NV; Board-certified, American Board of Foot and Ankle Surgery and American Board of Podiatric Medicine; Fellow, American College of Podiatric Medicine; Fellow, American College of Foot and Ankle Surgeons; Assistant Professor, University of Nevada Las Vegas School of Medicine, Las Vegas, NV; Adjunct Professor, Temple University School of Podiatric Medicine, Philadelphia, PA; Veterans Administration Podiatry Field Advisory Committee
Nicholas J. Perfetti, DPM Resident, Corporal Michael J. Crescenz Veteran’s Administration Medical Center, Philadelphia, PA
Alexander T. Ruutiainen, MD Service Chief of Diagnostic Radiology, Corporal Michael J. Crescenz Veteran’s Administration Medical Center, Philadelphia PA
Steven Shannon, DPM, FACFAS Attending Podiatric Physician, Corporal Michael J. Crescenz Veteran’s Administration Medical Center, Phila- delphia, PA; Adjunct Associate Professor, Temple University School of Podiatric Medicine, Philadelphia, PA; Fellow, American College of Foot and Ankle Surgeons
Sarah A. Spizzirri, DPM, FACFAS Private Practice, Christie Clinic, Department of Foot and Ankle Surgery, Champaign, IL; Fellow, American College of Foot and Ankle Surgeons.
Jacob Wynes, DPM, MS, FACFAS Assistant Professor, Program Director, Limb Preservation Deformity Correction Fellowship, Department of Orthopaedics, University of Maryland School of Medicine, Baltimore, MD
In This Issue:
FEATURE ARTICLE: Common Benign Soft Tissue Mass Affecting the Foot and Ankle
Kittra Owens, DPM
CONDENSATIONS and COMMENTARIES
Management of Primary Malignant Bone and Soft Tissue Tumors of Foot and Ankle: Is it Worth Salvaging?
Commentary by Jacob Wynes, DPM
Schwannoma of Foot and Ankle: Seven Case Reports and Literature Review
Commentary by Lisa R. Hobbs, DPM
Tenosynovial Giant Cell Tumor in the Foot and Ankle
Commentary by Sarah A. Spizzirri, DPM
Fat-Containing Soft-Tissue Masses in Children
Commentary by David W. Low, MD
Dermatofibrosarcoma Protuberans on Adult Toes: A Case Report and Review of the Literature
Commentary by Amy E. Bruce, DPM
Synovial Sarcoma of the Digits: A Case Report of an Unplanned Excision Commentary by Susan Gamble, DPM
Leiomyoma of the Foot: A Case Report and Literature Review
Commentary by Karen Galli, DPM
Peripheral Nerve Sheath Tumors of The Foot and Ankle
Commentary by Steven Shannon, DPM
Neural Fibrolipoma of the Ankle: A Case Report and Review of the Literature
Commentary by Nicholas J. Perfetti, DPM
MR Imaging of Common Soft Tissue Masses in the Foot and Ankle
Commentary by Alexander T. Ruutiainen, MD
AUDIO LECTURE 1: Introduction of Soft Tissue Tumors of Foot and Ankle: Part 1
Marija Ugrinich, DPM
AUDIO LECTURE 2: Introduction of Soft Tissue Tumors of Foot and Ankle: Part 2
William Harris IV, DPM